EA 7451 | Biotechnologie des tissus conjonctifs et cutanés
Accueil > Publications, communications et diffusion scientifiques > Publications scientifiques > 2012
Publications 2012
Bigot N, Beauchef G, Hervieu M, Oddos T, Demoor M, Boumediene K, Galéra P. NF-κB accumulation associated with COL1A1 transactivators defects during chronological aging represses type I collagen expression through a -112/-61-bp region of the COL1A1 promoter in human skin fibroblasts. J Invest Dermatol. 2012 Oct;132(10):2360-7.
Duval E, Baugé C, Andriamanalijaona R, Bénateau H, Leclercq S, Dutoit S, Poulain L, Galéra P, Boumédiene K. Molecular mechanism of hypoxia-induced chondrogenesis and its application in in vivo cartilage tissue engineering. Biomaterials. 2012 Sep;33(26):6042-51.
Meaume S, Perez J, Rethore V, Sebbane G, Dompmartin A, Bressieux JM, Leguyadec T, Tacca O, Bohbot S. Management of chronic wounds with an innovative absorbent wound dressing. J Wound Care. 2012 Jul;21(7):315-6, 318, 320-2.
Meaume S, Truchetet F, Cambazard F, Lok C, Debure C, Dalac S, Lazareth I, Sigal ML, Sauvadet A, Bohbot S, Dompmartin A; CHALLENGE Study Group. A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers. Wound Repair Regen. 2012 Jul-Aug;20(4):500-11
Euvrard S, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I, Broeders N, del Marmol V, Chatelet V, Dompmartin A, Kessler M, Serra AL, Hofbauer GF, Pouteil-Noble C, Campistol JM, Kanitakis J, Roux AS, Decullier E, Dantal J;TUMORAPA Study Group. Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med. 2012 Jul 26;367(4):329-39.
Renard E, Porée B, Chadjichristos C, Kypriotou M, Maneix L, Bigot N, Legendre F, Ollitrault D, De Crombrugghe B, Malléin-Gérin F, Moslemi S, Demoor M, Boumediene K, Galéra P. Sox9/Sox6 and Sp1 are involved in the insulin-like growth factor-I-mediated upregulation of human type II collagen gene expression in articular chondrocytes. J Mol Med (Berl). 2012 Jun;90(6):649-66.
Demoor M, Maneix L, Ollitrault D, Legendre F, Duval E, Claus S, Mallein-Gerin F, Moslemi S, Boumediene K, Galera P. Deciphering chondrocyte behaviour in matrix-induced autologous chondrocyte implantation to undergo accurate cartilage repair with hyaline matrix. Pathol Biol (Paris). 2012 Jun;60(3):199-207.
Baugé C, Girard N, Leclercq S, Galéra P, Boumédiene K. Regulatory mechanism of transforming growth factor beta receptor type II degradation by interleukin-1 in primary chondrocytes. Biochim Biophys Acta. 2012 May;1823(5):983-6.
Opletalová K, Blaizot X, Mourgeon B, Chêne Y, Creveuil C, Combemale P, Laplaud AL, Sohyer-Lebreuilly I, Dompmartin A. Maggot therapy for wound debridement: a randomized multicenter trial. Arch Dermatol. 2012 Apr;148(4):432-8.
Beauchef G, Bigot N, Kypriotou M, Renard E, Porée B, Widom R, Dompmartin-Blanchere A, Oddos T, Maquart FX, Demoor M, Boumediene K, Galera P. The p65 subunit of NF-κB inhibits COL1A1 gene transcription in human dermal and scleroderma fibroblasts through its recruitment on promoter by protein interaction with transcriptional activators (c-Krox, Sp1, and Sp3). J Biol Chem. 2012 Jan 27;287(5):3462-78.
Duval E, Baugé C, Andriamanalijaona R, Bénateau H, Leclercq S, Dutoit S, Poulain L, Galéra P, Boumédiene K. Molecular mechanism of hypoxia-induced chondrogenesis and its application in in vivo cartilage tissue engineering. Biomaterials. 2012 Sep;33(26):6042-51.
Meaume S, Perez J, Rethore V, Sebbane G, Dompmartin A, Bressieux JM, Leguyadec T, Tacca O, Bohbot S. Management of chronic wounds with an innovative absorbent wound dressing. J Wound Care. 2012 Jul;21(7):315-6, 318, 320-2.
Meaume S, Truchetet F, Cambazard F, Lok C, Debure C, Dalac S, Lazareth I, Sigal ML, Sauvadet A, Bohbot S, Dompmartin A; CHALLENGE Study Group. A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers. Wound Repair Regen. 2012 Jul-Aug;20(4):500-11
Euvrard S, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I, Broeders N, del Marmol V, Chatelet V, Dompmartin A, Kessler M, Serra AL, Hofbauer GF, Pouteil-Noble C, Campistol JM, Kanitakis J, Roux AS, Decullier E, Dantal J;TUMORAPA Study Group. Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med. 2012 Jul 26;367(4):329-39.
Renard E, Porée B, Chadjichristos C, Kypriotou M, Maneix L, Bigot N, Legendre F, Ollitrault D, De Crombrugghe B, Malléin-Gérin F, Moslemi S, Demoor M, Boumediene K, Galéra P. Sox9/Sox6 and Sp1 are involved in the insulin-like growth factor-I-mediated upregulation of human type II collagen gene expression in articular chondrocytes. J Mol Med (Berl). 2012 Jun;90(6):649-66.
Demoor M, Maneix L, Ollitrault D, Legendre F, Duval E, Claus S, Mallein-Gerin F, Moslemi S, Boumediene K, Galera P. Deciphering chondrocyte behaviour in matrix-induced autologous chondrocyte implantation to undergo accurate cartilage repair with hyaline matrix. Pathol Biol (Paris). 2012 Jun;60(3):199-207.
Baugé C, Girard N, Leclercq S, Galéra P, Boumédiene K. Regulatory mechanism of transforming growth factor beta receptor type II degradation by interleukin-1 in primary chondrocytes. Biochim Biophys Acta. 2012 May;1823(5):983-6.
Opletalová K, Blaizot X, Mourgeon B, Chêne Y, Creveuil C, Combemale P, Laplaud AL, Sohyer-Lebreuilly I, Dompmartin A. Maggot therapy for wound debridement: a randomized multicenter trial. Arch Dermatol. 2012 Apr;148(4):432-8.
Beauchef G, Bigot N, Kypriotou M, Renard E, Porée B, Widom R, Dompmartin-Blanchere A, Oddos T, Maquart FX, Demoor M, Boumediene K, Galera P. The p65 subunit of NF-κB inhibits COL1A1 gene transcription in human dermal and scleroderma fibroblasts through its recruitment on promoter by protein interaction with transcriptional activators (c-Krox, Sp1, and Sp3). J Biol Chem. 2012 Jan 27;287(5):3462-78.
Dernière modification : 16 février 2017
Soutenez l'équipe en versant votre taxe d'apprentissage
Si vous souhaitez soutenir nos programmes de recherche et aider à la formation de nouveaux chercheurs, vous pouvez nous adresser votre taxe d'apprentissage.Pour cela, nous contacter.
Université de Caen Normandie
Laboratoire Bioconnect
CHU niveau 3 | 5 avenue de la Côte de Nacre | 14032 Caen Cedex 5 | France
Laboratoire Bioconnect
CHU niveau 3 | 5 avenue de la Côte de Nacre | 14032 Caen Cedex 5 | France
